CIAAG joined 62 organizations in an open letter to members of the Intergovernmental Negotiating Body Bureau to uphold the human right to participate in international forums by ensuring the full and meaningful participation of civil society and communities throughout the treaty drafting and negotiation process.

CIAAG endorsed an open letter to the members of the United Nations General Assembly regarding the ECOSOC Committee on NGO's addressing a rapidly growing trend where decisions seem to be made for political reasons rather than on the merit of the application and where the vast majority of applications are "deferred" year after year.

CIAAG joined 31 organizations in a joint letter to the Biden Administration requesting transparency in clinical trials being funded by federal grant dollars, conducted by private academic institutuions and pharmaceutical companies.

CIAAG President, Lauren Deluca and Vice President, Shasta Rayne Harner both endorse "Open Letter to the Acting Director, Agency of Healthcare Research and Quality", advising that a formal complaint was submitted to the House of Representatives Committee on Government Oversight and Reform, on grounds of fraud and abuse in regards to the validity or lack thereof for methods applied in Comparative Outcomes Review 240.

CIAAG joined 72 organizations endorsing a joint proposal for equitable access to treatments, vaccines, and diagnostics, resulting from the ACT-Accelerator.

CIAAG joined 58 organizations endorsing a joint letter urging to accelerate the development, availability and equitable access to safe, quality, effective and affordable diagnostics, therapeutics and vaccines against coronavirus.

CIAAG endorsed a joint letter, COVID-19: Principles for Global Access, Innovation and Cooperation, promoting access for all, solidarity, and global cooperation toward the common goal of treatment and vaccinations to address the global health pandemic we are facing as a result of the COVID-19 outbreak.

CIAAG joined several organizations requesting amendments to the Consumer Financial Protection Bureau's proposed medical debt collection rule.

CIAAG joined 151 organizations, associations and institutions in endorsing the position statement: "Decision by the World Health Organization (WHO) to Withdraw Guidance Documents" – A Global Palliative Care Initiative.

CIAAG joined 50 organizations in an open letter to the delegates at the 72nd World Health Assembly on Transparency Resolution Negotiations.

CIAAG joined 70 Organizations in a Joint-Letter to Congress expressing our concerns regarding provisions included in the proposed NAFTA 2.0 which would entrench and expand prescription drug monopoly protections, thwart competition and undermine efforts to expand access to affordable medicines.

CIAAG joined 45 organizations urging congressional leaders to reject any measures that would increase drug costs for consumers, including rolling back the provisions in the Bipartisan Budget Act of 2018.